<DOC>
	<DOCNO>NCT00275834</DOCNO>
	<brief_summary>The primary aim study ass long-term weight loss efficacy zonisamide relative placebo obese patient prescribe dietary intervention .</brief_summary>
	<brief_title>Zonisamide Weight Reduction Obese Adults</brief_title>
	<detailed_description>This RCT compare two dos zonisamide placebo one year . A total 225 subject randomly assign one three treatment intervention Duke University Medical Centre . The primary outcome measure change body weight kilogram . Secondary outcome include change waist circumference , glycaemic inflammatory marker , lipid , food craving , hunger satiety , quality life , blood pressure heart rate .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Age 1865 year ; BMI 3050 Secondary obesity ; Significant cardiovascular disease ; Stroke , seizure disorder significant neurological disease ; Significant liver gallbladder disease ; Significant renal disease history kidney stone ; HIV positive status ; Diabetes mellitus ; Untreated unstable hypothyroidism Malignancy past 5 year ; Concomitant medication cause significant weight gain weight loss ; Concomitant use prescription OTC weight loss medication ; Had bariatric surgery planning surgery next 1 year ; Weight change 4 kg past 3 month ; Suicidal subject ; Major depression past 6 month ; History psychosis , bipolar disorder , severe personality disorder ; Subjects take antipsychotic mood stabiliser ; Alcohol substance abuse past 6 month ; Currently take zonisamide antiepileptic drug ; History hypersensitivity zonisamide sulfonamides ; Pregnant planning pregnancy next year , breastfeeding ; Severe physical disability ; Current participation commercial weight loss program planning participate ; Currently follow lowcarbohydrate , high protein , high fat diet ; Use investigational medication device ( current past 4 week )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>obesity treatment</keyword>
	<keyword>weight loss</keyword>
	<keyword>antiobesity drug</keyword>
	<keyword>zonisamide</keyword>
</DOC>